Wave Life Sciences, Inc. (WVE) › Weighted Average Diluted SharesWave Life Sciences, Inc. (WVE) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 51.83M2022-12-31: 78.86M2023-12-31: 106.10M2024-12-31: 138.28M2025-12-31: 168.65M168.65M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31168.65M+22.0%2026-02-26From 2025-01-012024-12-31138.28M+30.3%2026-02-26From 2024-01-012023-12-31106.10M+34.5%2026-02-26From 2023-01-012022-12-3178.86M+52.2%2025-03-04From 2022-01-012021-12-3151.83M—2023-03-23From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)